GlassScriptPhysician profile
Caitlin Sheehan
NPI 1033651260
$1,719.65
in general payments reported to CMS, 2019-2025
20 companies · $703 in 2025
The $703 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $84.56 · 2023: $388 · 2024: $389 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.95 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $667.01 | 2022-2025 | Briviact, Rystiggo, Nayzilam |
| Medtronic, INC. | $172.29 | 2021-2025 | Inceptiv |
| Neurocrine Biosciences, INC. | $160.86 | 2023-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $133.44 | 2022-2025 | Vyepti, Rexulti |
| Eisai INC. | $95.35 | 2024-2025 | |
| Abbvie INC. | $57.39 | 2025 | |
| Insightec,INC | $53.66 | 2025 | Exablate |
| Kyowa Kirin, INC. | $49.02 | 2024-2025 | Nourianz |
| Aucta Pharmaceuticals, INC. | $45.96 | 2025 | Motpoly Xr |
| Argenx US, INC. | $44.16 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Astrazeneca Pharmaceuticals LP | $40.56 | 2024 | Andexxa |
| Acadia Pharmaceuticals INC | $32.05 | 2025 | Daybue |
| Novartis Pharmaceuticals Corporation | $29.62 | 2023 | |
| Sk Life Science, INC. | $29.39 | 2025 | |
| Amneal Pharmaceuticals LLC | $28.88 | 2022-2025 | Crexont |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.00 | 2024 | Kcentra |
| Alexion Pharmaceuticals, INC. | $18.07 | 2025 | Ultomiris |
| Servier Pharmaceuticals LLC | $17.11 | 2025 | |
| Lilly USA, LLC | $13.48 | 2025 | Kisunla, Amyvid |
| Janssen Pharmaceuticals, INC | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.